Company Filing History:
Years Active: 2015
Title: Zdenek Hostomsky: Innovator in Monoclonal Antibodies
Introduction
Zdenek Hostomsky is a prominent inventor based in La Jolla, California. He is known for his significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His innovative work has led to advancements in medical research and therapeutic applications.
Latest Patents
Zdenek Hostomsky holds a patent for Anti Notch-1 antibodies. This invention is directed toward monoclonal antibodies that bind specifically to Notch1. In one embodiment, the antibodies bind to at least a first epitope and a second epitope, wherein the first epitope resides within the LinA domain of the Notch1 negative regulatory region (NRR), and the second epitope resides within the HD-C domain of the Notch1 NRR. This patent showcases his expertise in targeting specific proteins for therapeutic purposes.
Career Highlights
Zdenek Hostomsky is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to collaborate with other experts in the field and contribute to groundbreaking research. His work has been instrumental in advancing the understanding of monoclonal antibodies and their applications in medicine.
Collaborations
Some of Zdenek's notable coworkers include Kang Li and Ping Wei. Their collaborative efforts have further enhanced the research and development of innovative solutions in biotechnology.
Conclusion
Zdenek Hostomsky's contributions to the field of monoclonal antibodies exemplify the impact of innovation in biotechnology. His work continues to influence medical research and therapeutic advancements.